Bain Capital Life Sciences

Bain Capital Life Sciences Fund specializes in buyouts, inflection capital, growth capital, turnaround, and private equity investments.

Be the first to review

Independent rating of Bain Capital Life Sciences VC fund

Overall rating:
Not reviewed

About Bain Capital Life Sciences VC fund

Founded:
2016

How Bain Capital Life Sciences VC fund invests

Rounds:
Post, Series D, Series C, Series B, Series A
Average ticket size:
42.2M USD
Smallest investment:
15.4M USD
Biggest investment:
85.7M USD
Would lead round:
Yes
Would coinvest:
Yes
Countries where invested:
United States
Sectors of interest:
Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical, Life Science, Personal Health, Neuroscience, Medical Device, Health Diagnostics, Diabetes, Clinical Trials, Biopharma

Portfolio - latest investments by Bain Capital Life Sciences VC fund
Interius BioTherapeutics
Nuvalent
Nautilus Biotechnology
Amylyx Pharmaceuticals
X4 Pharmaceuticals
Crinetics Pharmaceuticals
Imperative Care
ViaCyte
Freenome
Tango Therapeutics

Founders' reviews of Bain Capital Life Sciences VC fund

Be the first one to review Bain Capital Life Sciences.
Nobody reviews Bain Capital Life Sciences just yet. Help other founders navigate by writing about your experience with them.
Similar funds